Alterity Therapeutics Ltd.ASX: ATH

Approval of PBT2 Orphan Designation for Huntingtons Disease

Feb 10, 2016 at 8:19 PM EST · Issued by Alterity Therapeutics Ltd.

Filed with ASX · Feb 10, 2016 at 8:19 PM EST

6ix hasn’t read this filing yet.

Follow Alterity Therapeutics into a list and get an email when it puts out news.